22-42060373-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000262.3(NAGA):c.1142G>A(p.Arg381Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000262.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAGA | NM_000262.3 | c.1142G>A | p.Arg381Gln | missense_variant | 9/9 | ENST00000396398.8 | NP_000253.1 | |
NAGA | NM_001362848.1 | c.1142G>A | p.Arg381Gln | missense_variant | 10/10 | NP_001349777.1 | ||
NAGA | NM_001362850.1 | c.1142G>A | p.Arg381Gln | missense_variant | 10/10 | NP_001349779.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAGA | ENST00000396398.8 | c.1142G>A | p.Arg381Gln | missense_variant | 9/9 | 1 | NM_000262.3 | ENSP00000379680 | P1 | |
NAGA | ENST00000402937.1 | c.1142G>A | p.Arg381Gln | missense_variant | 10/10 | 5 | ENSP00000384603 | P1 | ||
NAGA | ENST00000403363.5 | c.1142G>A | p.Arg381Gln | missense_variant | 10/10 | 5 | ENSP00000385283 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152036Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249232Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134900
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461540Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727074
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74260
ClinVar
Submissions by phenotype
Alpha-N-acetylgalactosaminidase deficiency type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2019 | This variant is present in population databases (rs144771084, ExAC 0.01%). This sequence change replaces arginine with glutamine at codon 381 of the NAGA protein (p.Arg381Gln). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and glutamine. This variant has not been reported in the literature in individuals with NAGA-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at